NanoViricides Inc. (NNVC)

[arvitar]

No, they do not "say the same thing".

The 2012 10K reported an accumulated deficit of $22,894,827. The recent 10K reports $64,824,201. That's 3X more money spent, with still not a single IND-approved candidate.

That's a difference.


The 2012 10K has this optimistic statement regarding its ability to raise capital:

p. F-18 "The Company continues to successfully raise additional capital"

The 2016 10K contains no such statement.

That's another difference.

There are a few thousand other differences between what the 2012 10K says, and what the 2016 10K says.